<DOC>
	<DOCNO>NCT00129181</DOCNO>
	<brief_summary>This study investigate whether change 123iodine-2ß- carbomethoxy-3ß- ( 4-iodophenyl ) tropane ( [ 123I ] ß-CIT ) uptake short-term treatment levodopa compare either dopamine agonist placebo .</brief_summary>
	<brief_title>Study Effects Dopaminergic Medications Dopamine Transporter Density Subjects With Parkinson 's Disease</brief_title>
	<detailed_description>This multi-center , open-label study short-term treatment levodopa cabergoline striatal DATscan uptake early Parkinson 's disease . Approximately 120 Parkinson 's disease subject randomize receive either carbidopa/levodopa , cabergoline treatment twelve week period . Subjects undergo SPECT image DATscan screen 12 week . After twelve week carbidopa/levodopa cabergoline treatment withdrawn subject undergo SPECT image DATscan 8 week ( 20 week baseline ) .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dopamine</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Cabergoline</mesh_term>
	<mesh_term>Carbidopa , levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>The subject age 40 year old . Written inform consent obtain . Subjects clinical diagnosis idiopathic Parkinson 's disease . Hoehn Yahr stag subject III . The subject atypical druginduced Parkinson 's disease . The subject dementia . The subject clinically significant abnormal laboratory value , and/or clinically significant unstable medical psychiatric illness . The subject pregnant .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>parkinson</keyword>
	<keyword>brain imaging</keyword>
	<keyword>diagnosis</keyword>
</DOC>